Please login to the form below

Not currently logged in
Email:
Password:

neglected tropical diseases

This page shows the latest neglected tropical diseases news and features for those working in and with pharma, biotech and healthcare.

The power of pharma businesses to drive social change

The power of pharma businesses to drive social change

For example, we have a focus on, and commitment to, combatting neglected tropical diseases (NTDs). ... Our research teams are collaborating with peers from organisations around the world to help in the development of effective treatments for diseases

Latest news

  • GSK tops pharma access to medicines table GSK tops pharma access to medicines table

    drive to tackle neglected tropical diseases," commented ATMI founder and chief executive Wim Leereveld. ... the pipeline tackling diseases affecting developing countries to 327 at last count.

  • Video for neglected tropical diseases challenges viewers Video for neglected tropical diseases challenges viewers

    The seven diseases represent 90 per cent of the total global neglected tropical disease (NTD) burden. ... In 2012 the World Health Organization issued its Accelerating Work to Overcome the Global Impact of Neglected Tropical Diseases roadmap for tackling

  • Takeda buys vaccines specialist Inviragen Takeda buys vaccines specialist Inviragen

    Its lead candidate is DENVax, a four-strain recombinant viral vaccine for the prevention of dengue infection – the most widespread tropical disease after malaria. ... The acquisition also gives Takeda scope to tackle neglected tropical diseases, which

  • Pharma companies partner with Japanese government Pharma companies partner with Japanese government

    research funding that will help tackle HIV, malaria, tuberculosis and neglected tropical diseases (NTDs). ... related to access to medicines in order to effectively combat infectious diseases, including neglected tropical diseases.”.

  • Medicine donations helping in battle against tropical diseases Medicine donations helping in battle against tropical diseases

    WHO said it is reporting “unprecedented progress against 17 neglected tropical diseases”, including two due to be eradicated worldwide. ... projects targeting neglected tropical diseases during 2012 – a 40 per cent increase from 2011.

More from news
Approximately 3 fully matching, plus 10 partially matching documents found.

Latest Intelligence

  • Reaching new heights Reaching new heights

    The seemingly intractable problems of neglected tropical diseases, compounded by poverty and war in Africa, finally appear to be responding to philanthropy-funded research and engagement, resulting in fundamental changes by ... biologics. Patients will

  • Pharma deals in August 2015 Pharma deals in August 2015

    $65m. Antisense oligonucleotides target RNA and the new collaboration will extend into renal diseases, cardiovascular and metabolic fields. ... Introduced by the FDA in 2007, a priority review voucher (PRV) is an incentive for companies to invest in

  • Pharma deals during November 2014 Pharma deals during November 2014

    from ten months down to six). Introduced by the FDA in 2007, a PRV is an incentive for companies to invest in treatments for neglected tropical diseases. One of 16 tropical ... diseases that qualify is leishmaniasis, for which Knight's Impavido

  • Interview: Charles Mgone, EDCTP Interview: Charles Mgone, EDCTP

    We will ask them what areas they are interested in regarding our scope in HIV, TB, malaria and now neglected tropical diseases.”. ... It is all looking very positive.”. Mgone explains that EDCTP is expanding its remit to include neglected infectious

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics